NSG BioLabs

About NSG BioLabs

NSG BioLabs is a pioneering startup that provides co-working laboratory and office spaces specifically designed for biotechnology startups. Located in Singapore, NSG BioLabs offers a 22,000 square foot facility equipped with state-of-the-art laboratory equipment and office amenities. The company caters to early-stage biotech companies, providing them with the necessary infrastructure to conduct cutting-edge research and development.

NSG BioLabs operates in the biotechnology market, which is a rapidly growing sector focused on the use of living organisms and systems to develop products and technologies. The company’s business model revolves around leasing laboratory and office spaces to biotech startups. By offering fully equipped labs and office spaces, NSG BioLabs allows these startups to focus on their research without the burden of setting up their own facilities. This model not only saves time and money for the startups but also fosters a collaborative environment where companies can share ideas and resources.

The company makes money by charging rent for the use of its facilities. Additionally, NSG BioLabs offers preferred rates for consumables through its Research Support Center (RSC), which provides essential supplies and equipment at discounted prices. This adds another revenue stream while also supporting the startups in their research activities.

NSG BioLabs ensures compliance with national guidelines for handling chemical and biological materials, laboratory safety, and waste disposal. The facility is equipped with emergency power systems for critical storage items, storage facilities for hazardous substances, and Class 3 flammable materials. The comprehensive list of equipment available includes qRT PCRs, thermocyclers, biosafety cabinets, centrifuges, cell counters, and more, making it a one-stop-shop for biotech research needs.

The company was founded by scientists and entrepreneurs with extensive experience in synthetic biology and venture capital. Notable partners include Timothy Lu, a leader in synthetic biology, and Hingge Hsu, who has a strong background in venture capital and investment banking.